Antibodies bound to nuclear antigens contribute to SLE pathogenesis by facilitating TLR7-mediated activation of immune cells, such as plasmacytoid dendritic cells (pDCs) and neutrophils, and via immune complex deposition (1). This evidence concerns the gene TLR7 and systemic lupus erythematosus.